{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-000553","form_type":"8-K","ticker":"RDNT","cik":"0000790526","company_name":"RadNet, Inc.","filed_at":"2022-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.777843+00:00","generated_at":"2026-06-27T14:28:25.255429+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"RadNet acquires Aidence and Quantib, outlines AI strategy for cancer screening and operations","bullets":["Acquired Aidence (AI for lung cancer screening) and Quantib (AI for prostate MRI) to bolster AI portfolio.","Conference call highlighted AI opportunities in clinical enhancements, business ops, and revenue growth.","Dr. Greg Sorensen, CEO of DeepHealth, leads RadNet's AI division.","Financial terms of the acquisitions were not disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-000553","json":"https://secwatch.observer/filing/0001683168-22-000553.json","markdown":"https://secwatch.observer/filing/0001683168-22-000553.md","text":"https://secwatch.observer/filing/0001683168-22-000553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/790526/000168316822000553/0001683168-22-000553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790526/000168316822000553/radnet_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:28:25.255429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}